Inhibitors

A cell-permeable triazinyl-phenyl-pyridinylurea compound that acts as a potent inhibitor against mTOR (IC 50 = 0.42 nM) and PI 3-K (IC 50 = 8, 24, 74, 77, 14, and 11 nM against isoform &#945, &#946, &#947, &#948, &#945 E545K mutant, and &#945

A cell permeable, selective inhibitor of PI 3-K&#948 (IC 50 = 1.82, 0.

Application For use in kinase assays. Research Category All Quality Routinely evaluated as an inhibitor cocktail Physical form 20mM MOPS, pH 7.

Biochem/physiol Actions Protein Target: PKA Target Sub-Family: AGC Quality Routinely evaluated by inhibition of PKA catalytic subunit (14-114). Physical form Lyophilized powder (from H 2 O) Storage and Stability Lyophilized: Stable for 2 years at

A selective, reversible, and substrate competitive inhibitor of protein kinase C &#950 and protein kinase C &#953 (PKC &#950/&#953 ) isozymes. Non-cell-permeable protein kinase C &#950 and protein kinase C &#953 pseudosubstrate sequence

A cell-permeable benzoxoloazepinolone compound that effectively inhibits syntide-2 (Cat. No.

A cell-permeable gedunin analog that directly targets PKR via reversible interaction inhibits PKR-mediated cellular events by disrupting PKR signaling complexes assembly, such as I&#954K complex and inflammasome/pyroptosome, resulting in effective

An oxindole compound that serves as a negative control for PKR Inhibitor (Cat. No.

A cell-permeable pyridinyl-phenylacetamide that is reported to be 60-times more potent than IWP-2 (Cat. No.

A cell-permeable C59 (Cat. No.

PrEST Antigen MIA2 melanoma inhibitory activity 2, 100ul UN

PrEST Antigen MIA2 melanoma inhibitory activity 2, 100ul UN